Publications by authors named "R N Nanda"

Background: Delayed reactions to hyaluronic acid (HA) fillers have been reported following various immunologic and infectious triggers.

Aim: Herein, we describe cases of delayed immunologic reactions (DIRs) following HA-soft tissue augmentation fillers precipitated by triggers not previously described in the literature.  Patients: Case 1 describes a 57-year-old female with DIR to HA-filler following a motor vehicle accident in the marionette lines and nasolabial folds.

View Article and Find Full Text PDF

Diabetic peripheral neuropathy is a common complication of diabetes mellitus that has dire outcomes, affecting the economic profile of a country. Despite the multifactorial background of the pathogenesis of this disease, the mechanism underlying peripheral neuropathy is still unclear. Endothelial damage is a new determinant of pathogenesis, with endocan as a potential biomarker for endothelial dysfunction in diabetic peripheral neuropathy patients.

View Article and Find Full Text PDF
Article Synopsis
  • Basal cell carcinoma (BCC) is the most prevalent form of skin cancer, often manifesting as a scaly red patch, particularly in its superficial subtype.
  • The case report highlights an elderly patient whose large BCC on the left scalp was mistakenly treated as plaque psoriasis for years.
  • It emphasizes the importance of scouting biopsies for accurate cancer mapping and discusses serial excisions via Mohs micrographic surgery as an effective treatment option for large BCCs located in high-tension areas.
View Article and Find Full Text PDF

Background: Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have improved the efficacy of endocrine therapy in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer (BC) and are now used in both early-stage and metastatic disease. Recent case reports suggest that pseudo-serum creatinine (Scr) elevations are likely a class effect of CDK4/6i.

Methods: This single-center retrospective analysis included patients aged ≥18 years who received at least one dose of palbociclib, ribociclib, or abemaciclib for the treatment of HR+/HER2- BC in the early or advanced setting.

View Article and Find Full Text PDF
Article Synopsis
  • The audit aimed to assess and improve the completeness and accuracy of the National Joint Registry (NJR) dataset specifically for elbow arthroplasty surgeries.
  • In a two-phase approach, Phase 1 compared NJR data with NHS England Hospital Episode Statistics (HES), identifying thousands of unmatched and inaccurate records, particularly for radial head arthroplasties (RHAs).
  • Phase 2 involved collaboration among 142 NHS hospitals to correct and update records, resulting in an improved completeness of the NJR dataset from 63% to 93% and accuracy from 94% to 98%.
View Article and Find Full Text PDF